1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Optic Atrophy, Hereditary, Leber: new trials by email Literature Review of Optic Atrophy, Hereditary, Leber trials Research Report on Optic Atrophy, Hereditary, Leber
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Efficacy and Safety of Raxone in LHON Patients Idebenone - Leber's Hereditary Optic Neuropathy (LHON) | Phase 4 | Completed | Santhera Pharmaceuticals | 199 | 2016-05-01 | 2023-04-21 |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Cranial Nerve Diseases (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Metabolic Diseases (1) · Mitochondrial Diseases (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Nutritional and Metabolic Diseases (1) · Optic Atrophies, Hereditary (1) · Optic Atrophy (1) · Optic Nerve Diseases (1)
idebenone (1)
Austria (1) · Belgium (1) · Bulgaria (1) · Germany (1) · Italy (1) · Poland (1) · Portugal (1) · Spain (1) · United Kingdom (1) · United States (1)